1. Laying The Foundation For Viral Safety

    Mitigating the risk of viral contamination in vaccines, cell, and gene therapies.

  2. Reducing Mab Clinical Trial Costs By Using Different Agarose Protein A Chromatography Resins

    New data from a HTPD comparability case study is shared using three Protein A resins, with key data including yield, purity, DNA & HCP clearance, and Protein A leakage.

  3. What Is Pharmaceutical Innovation, Anyway? Italy’s New Algorithm & The Global Trend

    Innovation has long been a topic of focus in the pharmaceutical industry, with developers striving for it, regulators and payers demanding it, and everyone — from patients to manufacturers — worrying about who is going to pay for it. Something that often gets lost in the conversation is: What exactly do we mean when we talk about “innovation”?

  4. Strategic Facility Planning: Biopharma/Pharma

    Do your facility strategies align with your business plan? Do you require big picture results backed by detailed information and data?

  5. Understanding And Defining Laboratory Capacity In Biopharma

    Examine the options available for measuring your laboratory capacity.

  6. Viral Safety In Monoclonal Antibody Manufacturing

    Experts share their unique perspectives on the various technologies to prevent, detect, and remove virus contamination.

  7. Modular Biomanufacturing Facilities: Cell and Gene Therapy Development

    The alarming rate of cancer pervasiveness around the world has caused the spike in demand for gene therapy treatment.

  8. Advances In Upstream Technologies Reduce Viral-Contamination Risks

    Multilayered approach includes virus-resistant CHO cell lines, advanced filtration technologies, and careful raw material selection.

  9. How To Successfully Manage Packaging And Labeling During Pharma Product Launches

    If you are charged with any of the tasks that lead to a successful product launch in the pharmaceutical industry, you know how critical it is to execute a multitude of steps successfully. Among these are agreement by marketing on the look and design of the campaign, completion of clinical trials, project management, testing of active pharmaceutical ingredients, the completion of a trial production batch, receipt of all materials at the production site, production scheduling, regulatory agency submissions, trademark registration, and a host of others.

  10. 10 Steps To Develop A Sustainable Training Program For Pharma Operations

    Investing in training for employees in the life sciences and biopharmaceuticals industries generates quantifiable returns that go far beyond simply imparting specific, task-oriented knowledge. For example, effective and thoughtfully planned onboarding and sustainable training are key elements in attaining a culture of quality throughout the organization. Furthermore, inadequate training contributes to process and product variability.